The strategic review will include an assessment of the 70.68% shareholding of Novartis AG in Novartis India. Novartis said there is no assurance that the strategic review of Novartis India will be completed in 2024, or that the outcome would result in the implementation of any transaction.
from Stocks-Markets-Economic Times https://ift.tt/ZNRJ1Fd
Novartis puts its India-listed entity for up for sale
Related Posts:
Stocks in focus: Indiabulls Housing, JK Tyre, Coforge and more- ETMarkets Morning Podcast: Indian crypto investors make a killing on price arbitrage
- Japanese shares inch higher as chipmakers track overnight gains in US peers
- RBI makes mobile wallet interoperability mandatory from FY23
- Buy or Sell: Stock ideas by experts for May 20, 2021
0 Comments:
Post a Comment